The use of B-type natriuretic peptide to diagnose congestive heart failure.
This paper explains the background and current use of B-type natriuretic peptide (BNP) assays to differentiate congestive heart failure (CHF) from other causes of dyspnea. With a large and growing elderly population, CHF is being diagnosed much more often in emergency rooms in the United States. Doc...
| Publicado en: | Clinical Laboratory Science Vol. 19; no. 4; pp. 214 - 218 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
American Society for Clinical Laboratory Science
Fall2006
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106247539&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106247539 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0894959X IKL jtl: Clinical Laboratory Science issn: 0894959X maglogo: N pubinfo: dt: Fall2006 vid: 19 iid: 4 pid: 13703 pub: American Society for Clinical Laboratory Science place: Dundee, Michigan artinfo: ui: 106247539 2009381369 NLM17181125 106247539 ppf: 214 ppct: 4 formats: fmt: @attributes: type: P tig: atl: The use of B-type natriuretic peptide to diagnose congestive heart failure. aug: au: Gray JR affil: Department of Pathology, University of Maryland School of Medicine, 10 South Pine Street, MSTF 7th floor, Aug-65, Baltimore 21201-1192, USA. jgray@som.umaryland.edu sug: subj: Heart Failure Diagnosis Natriuretic Peptide, Brain Diagnostic Use Chemistry, Clinical Methods Natriuretic Peptide, Brain Physiology Point-of-Care Testing ab: This paper explains the background and current use of B-type natriuretic peptide (BNP) assays to differentiate congestive heart failure (CHF) from other causes of dyspnea. With a large and growing elderly population, CHF is being diagnosed much more often in emergency rooms in the United States. Doctors need a way to quickly distinguish whether a patient with respiratory distress is suffering from cardiac insufficiency or another etiology. BNP is released from the ventricles in response cardiac overload from CHF or some other form of left ventricular systolic dysfunction. Therefore, the detection and measurement of BNP is a fast and accurate method of determining if CHF is the cause of a patient's breathing difficulties. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|